IL78829A - Activator preparation for converting protein c,antithrombotic composition comprising it and method for quantitatively assaying protein c - Google Patents

Activator preparation for converting protein c,antithrombotic composition comprising it and method for quantitatively assaying protein c

Info

Publication number
IL78829A
IL78829A IL78829A IL7882986A IL78829A IL 78829 A IL78829 A IL 78829A IL 78829 A IL78829 A IL 78829A IL 7882986 A IL7882986 A IL 7882986A IL 78829 A IL78829 A IL 78829A
Authority
IL
Israel
Prior art keywords
protein
converting
antithrombotic composition
activator preparation
quantitatively assaying
Prior art date
Application number
IL78829A
Other languages
English (en)
Other versions
IL78829A0 (en
Original Assignee
Pentapharm Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pentapharm Ag filed Critical Pentapharm Ag
Publication of IL78829A0 publication Critical patent/IL78829A0/xx
Publication of IL78829A publication Critical patent/IL78829A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/462—Snake venom from Agkistrodon sp., e.g. acutase, ACTE
    • G01N2333/4626—Snake venom from Agkistrodon sp., e.g. acutase, ACTE from Agkistrodon contortrix contortrix (copperhead snake); Protac (R)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL78829A 1985-05-29 1986-05-19 Activator preparation for converting protein c,antithrombotic composition comprising it and method for quantitatively assaying protein c IL78829A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH226785 1985-05-29
CH413585 1985-09-25
CH508785 1985-11-28

Publications (2)

Publication Number Publication Date
IL78829A0 IL78829A0 (en) 1986-09-30
IL78829A true IL78829A (en) 1990-08-31

Family

ID=27173588

Family Applications (1)

Application Number Title Priority Date Filing Date
IL78829A IL78829A (en) 1985-05-29 1986-05-19 Activator preparation for converting protein c,antithrombotic composition comprising it and method for quantitatively assaying protein c

Country Status (10)

Country Link
US (1) US4849403A (xx)
EP (1) EP0203509B1 (xx)
JP (1) JPH0736760B2 (xx)
AU (1) AU605462B2 (xx)
CA (1) CA1286223C (xx)
DE (1) DE3678489D1 (xx)
DK (1) DK165199C (xx)
ES (2) ES8801037A1 (xx)
IL (1) IL78829A (xx)
NO (1) NO166303C (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3536903A1 (de) * 1985-10-16 1987-04-16 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung von protein c
DE3607559A1 (de) * 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
IT1197891B (it) * 1986-10-17 1988-12-21 Instrumentation Lab Spa Metodo per la determinazione dell'attivita' biologica della proteina c nel plasma umano, e relativi reagenti
AU646633B2 (en) * 1989-02-17 1994-03-03 Codon Soluble analogs of thrombomodulin
FR2658517B2 (fr) * 1989-04-12 1992-06-19 Fondation Nale Transfusion San Preparation de la proteine c activee et solution de proteine c activee ainsi obtenue.
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
DE4203965A1 (de) * 1992-02-11 1993-08-12 Max Planck Gesellschaft Antidot fuer hirudin und synthetische thrombininhibitoren
PL181102B1 (pl) * 1993-01-29 2001-05-31 Dahlbaeck Bjoern Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
ES2240972T3 (es) * 1993-11-12 2005-10-16 Gilead Sciences, Inc. Mutantes de la trombina.
US7060484B1 (en) 1993-11-12 2006-06-13 Gilead Sciences, Inc. Polypeptides and coagulation therapy
WO1995030429A1 (en) * 1994-05-04 1995-11-16 Board Of Trustees Of The University Of Arkansas Novel ophthalmologic uses of protein c
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
US6630137B1 (en) 1997-04-28 2003-10-07 Eli Lilly And Company Activated protein C formulations
EA002149B1 (ru) 1997-04-28 2001-12-24 Эли Лилли Энд Компани Улучшенные способы приготовления активированного белка с
US7204981B2 (en) * 2000-03-28 2007-04-17 Eli Lilly And Company Methods of treating diseases with activated protein C
EP1289543A2 (en) 2000-05-24 2003-03-12 Eli Lilly And Company Formulations and methods for treating hypercoagulable states
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US20050143283A1 (en) * 2002-03-08 2005-06-30 Eli Lilly And Company Activated protein c formulations
EP1367135A1 (en) * 2002-05-29 2003-12-03 Pentapharm AG Improved method for the assessment of thrombin formation in blood or plasma
CN102692511B (zh) * 2012-06-08 2015-04-15 上海太阳生物技术有限公司 蛋白c(pc)测定试剂盒(发色底物法)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1293795A (en) * 1969-07-04 1972-10-25 Twyford Lab Ltd Improvements relating to anticoagulants
SE420321B (sv) * 1973-09-03 1981-09-28 Fargal Pharmasint Lab Biochim Kromatografisk extraktion och isolering av enzymatisk komponent fran ormgift
CH626917A5 (xx) * 1976-08-17 1981-12-15 Pentapharm Ag
US4341762A (en) * 1981-04-07 1982-07-27 Haast William E Use of snake venoms for treatment of neurological and related disorders
US4485176A (en) * 1982-06-28 1984-11-27 E. I. Du Pont De Nemours & Company Turbidimetric method for measuring protein in urine and cerebrospinal fluid
DE3330699A1 (de) * 1983-08-25 1985-03-07 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur gleichzeitigen bestimmung von fibrinogen und fibrinogen-spaltprodukten im plasma

Also Published As

Publication number Publication date
DK224886A (da) 1986-11-30
JPS61280298A (ja) 1986-12-10
NO862118L (no) 1986-12-01
EP0203509A3 (en) 1988-10-05
DK224886D0 (da) 1986-05-14
NO166303B (no) 1991-03-18
CA1286223C (en) 1991-07-16
AU5736986A (en) 1986-12-04
EP0203509B1 (de) 1991-04-03
ES8801037A1 (es) 1987-12-01
JPH0736760B2 (ja) 1995-04-26
DK165199B (da) 1992-10-19
ES557670A0 (es) 1988-07-16
US4849403A (en) 1989-07-18
ES555428A0 (es) 1987-12-01
AU605462B2 (en) 1991-01-17
DK165199C (da) 1993-03-01
DE3678489D1 (de) 1991-05-08
IL78829A0 (en) 1986-09-30
NO166303C (no) 1991-06-26
EP0203509A2 (de) 1986-12-03
ES8802471A1 (es) 1988-07-16

Similar Documents

Publication Publication Date Title
IL78829A (en) Activator preparation for converting protein c,antithrombotic composition comprising it and method for quantitatively assaying protein c
EP0240975A3 (en) Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
EP0223958A3 (en) Novel copolyamideimides, prepolymers therefor and method for their preparation
GB8429846D0 (en) Analysis of polymeric protein products
AU601996B2 (en) Shampoo method and composition
AU594399B2 (en) Lubricating composition and method
EP0224590A4 (en) METHOD FOR THE ANALYSIS OF AN ACTIVE SUBSTANCE ON THE SURFACE OF MAN'S LUNGS AND REAGENT KIT FOR USE WITH SAID METHOD.
IL82840A0 (en) Method and compositions for the determination of occult blood
IL74205A0 (en) Method for performing enzyme assays and chemical compositions for performing the method
AU3916985A (en) Method and composition for biological testing using magnetic spheres
AU4407285A (en) Methods and apparatus for carrying out clinical, chemical and biological testing
IL71941A0 (en) Peptide derivatives and use thereof for quantitatively assaying enzymes
EP0273571A3 (en) Separating-agents composition and method using same
DE3665866D1 (en) Method for silalactone preparation and use
ZA86911B (en) Modified enzyme and process for its preparation
EP0260707A3 (en) Method for assaying plasma protein and measuring kit for the same
BG48273A1 (en) Polymerisationable oligoimide and method for its preparation
BG43441A1 (en) 2- hydroxylamino- 4, 5- dimetoxybenamide and method for its preparation
BG40873A1 (en) Hydroinsulating composition and method for its manufacture
BG41902A1 (en) 4- substituted- 2- dialkylamido- 2- oxo- 2, 5- dihydro- oxaphosphols and method for their preparation
ZA88306B (en) Anchoring composition,cartridge and method
BG40400A1 (en) Alpha- (benzoxazol- 2- ylthio) ketones, method for their preparation and use
BG52037B2 (en) Composition, method for its preparation and method for the application of cold hydroinsulation paste
BG41901A1 (en) N, n- dialkylamido- o- alkyl- 3- alkyl- 1, 2- alkadienephosphonates and method for their preparation
PT83107A (en) Method for determining the concentration of imunoglobuline e in human serum

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired